Yes, but only under license after extensive testing on tissue culturrd, and only on relevant model species, and then only for medications for which understanding of system-wide effects is required. Non-medical testing, LD testing and uninformative model species shoulf be restricted and discouraged
Будьте першим, хто відповість на це відповідь .